This almost eliminated mis-pairing between the introduced EBV-Sc-TCR and endogenous TCR chains, and we further enhanced tumor-specific TCR expression, functional avidity, and IL-2 production by introducing an extra intra-chain disulfide bond between the Vα and the poly-linker (91). The gene discussed is IL2; the disease is neoplasm.